Key Takeaways
- Clinical Bottom Line
- Differentiating the Fluid-Filled Cavity
Clinical Bottom Line
| Cyst Type | Endoscopic Ultrasound (EUS) Morphology | Malignant Potential |
|---|---|---|
| Serous Cystadenoma (SCA) | Microcystic, “honeycomb” appearance with a central calcified scar. | Virtually zero risk (<1%). Safely ignored. |
| Mucinous Cystic Neoplasm (MCN) | Macrocystic, thick-walled cyst typically found in the body/tail (mostly in women). | High risk; frequently harbors invasive carcinoma. |
| IPMN (Main Duct) | Massive, diffuse dilation of the main pancreatic duct (>10mm) with mural nodules. | Extreme risk (>60%); absolute mandate for surgical resection (Whipple). |
Differentiating the Fluid-Filled Cavity
The incidental discovery of a pancreatic cyst on a routine abdominal CT scan triggers a massive wave of patient anxiety. The endoscopist’s primary objective is utilizing Endoscopic Ultrasound (EUS) to physically categorize the cyst into one of three buckets: completely benign, pre-malignant requiring surveillance, or actively malignant requiring immediate surgery.
The Threat of the Mural Nodule
Intraductal Papillary Mucinous Neoplasms (IPMNs) are the most heavily surveilled cysts. They grow directly out of the pancreatic ductal epithelium, secreting massive volumes of thick, viscous mucin that physically dilates the ducts. While “Side-Branch” IPMNs carry a moderate cancer risk and are surveilled annually by EUS, “Main-Duct” IPMNs are notoriously aggressive. The specific high-resolution EUS finding that immediately terminates surveillance and triggers surgical resection is the “Mural Nodule”—a solid, fleshy protrusion growing directly from the inside wall of the cyst cavity, representing a focal area of high-grade dysplasia or frank adenocarcinoma actively forming.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
